GRAPPA 2023: Major Projects, Key Advances, and Milestones

Affiliations

¹ G. Ayan, MD, Division of Rheumatology, Department Internal Medicine, Hacettepe University Medical Faculty, Ankara, Turkey.
² S.Z. Aydin, MD, Division of Rheumatology, Faculty of Medicine, University of Ottawa, and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
³ L.C. Coates, MBChB, PhD, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
⁴ L. Eder, MD, PhD, Division of Rheumatology, Department of Medicine, Women's College Hospital, University of Toronto, Toronto, Ontario, Canada.
⁵ D.D. Gladman, MD, Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, University Health Network, and Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
⁶ P.S. Helliwell, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
⁷ G.S. Kaeley, MBBS, University of Florida College of Medicine, Jacksonville, Florida, USA.
⁸ A. Kavanaugh, MD, Division of Rheumatology, Allergy, and Immunology, University of California San Diego, La Jolla, California, USA.
⁹ P.J. Mease, MD, Rheumatology Research, Swedish Medical Center, and University of Washington, Seattle, Washington, USA.
¹⁰ S.R. Pennington, PhD, O. FitzGerald, MD, Conway Institute for Biomolecular Research, School of Medicine, University College Dublin, Dublin, Ireland.
¹¹ F. Proft, MD, Department of Gastroenterology, Infectiology and Rheumatology (including Nutrition Medicine), Charité - Universitätsmedizin, Berlin, Germany.
¹² E.R. Soriano, MD, MSc, Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, and Instituto Universitario, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
¹³ S.R. Pennington, PhD, O. FitzGerald, MD, Conway Institute for Biomolecular Research, School of Medicine, University College Dublin, Dublin, Ireland; oliver.fitzgerald@ucd.ie.

PMID: 39009384
DOI: 10.3899/jrheum.2024-0266

GRAPPA 2023: Major Projects, Key Advances, and Milestones

Gizem Ayan et al. J Rheumatol. 2024.

. 2024 Oct 1;51(Suppl 2):65-69.

doi: 10.3899/jrheum.2024-0266.

Authors

Affiliations

¹ G. Ayan, MD, Division of Rheumatology, Department Internal Medicine, Hacettepe University Medical Faculty, Ankara, Turkey.
² S.Z. Aydin, MD, Division of Rheumatology, Faculty of Medicine, University of Ottawa, and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
³ L.C. Coates, MBChB, PhD, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
⁴ L. Eder, MD, PhD, Division of Rheumatology, Department of Medicine, Women's College Hospital, University of Toronto, Toronto, Ontario, Canada.
⁵ D.D. Gladman, MD, Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, University Health Network, and Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
⁶ P.S. Helliwell, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
⁷ G.S. Kaeley, MBBS, University of Florida College of Medicine, Jacksonville, Florida, USA.
⁸ A. Kavanaugh, MD, Division of Rheumatology, Allergy, and Immunology, University of California San Diego, La Jolla, California, USA.
⁹ P.J. Mease, MD, Rheumatology Research, Swedish Medical Center, and University of Washington, Seattle, Washington, USA.
¹⁰ S.R. Pennington, PhD, O. FitzGerald, MD, Conway Institute for Biomolecular Research, School of Medicine, University College Dublin, Dublin, Ireland.
¹¹ F. Proft, MD, Department of Gastroenterology, Infectiology and Rheumatology (including Nutrition Medicine), Charité - Universitätsmedizin, Berlin, Germany.
¹² E.R. Soriano, MD, MSc, Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, and Instituto Universitario, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
¹³ S.R. Pennington, PhD, O. FitzGerald, MD, Conway Institute for Biomolecular Research, School of Medicine, University College Dublin, Dublin, Ireland; oliver.fitzgerald@ucd.ie.

PMID: 39009384
DOI: 10.3899/jrheum.2024-0266

Abstract

At the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2023 annual meeting, members were updated on a number of ongoing activities during the key project update session. These activities included the Axial Involvement in Psoriatic Arthritis (AXIS) cohort, the Axial Psoriatic Arthritis Molecular and Clinical Characterization study, the Diagnostic Ultrasound Enthesitis Tool (DUET) study, the Sex- and Gender-Based Analysis of the Effectiveness of Advanced Therapies in Psoriatic Arthritis (SAGE-PsA) study, the Health Initiatives in Psoriasis and Psoriatic Arthritis Consortium European States (HIPPOCRATES), the GRAPPA slide library, and the GRAPPA treatment recommendations.

Keywords: GRAPPA; education; project; psoriasis; psoriatic arthritis; research.

PubMed Disclaimer

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

GRAPPA 2023: Major Projects, Key Advances, and Milestones

Affiliations

GRAPPA 2023: Major Projects, Key Advances, and Milestones

Authors

Affiliations

Abstract

MeSH terms

LinkOut - more resources

Full Text Sources

Medical

Research Materials

Miscellaneous